Home   |   Research & Knowledge   |   Contact   |   Careers   |   FAQs
Gainers & Losers
Weekly Gainers
Weekly Losers
New Highs & New Lows
52 Week Highs
52 Week Lows
Advance and Decline
Bulk Deals
Block Deals
Detailed Quotes
Company Background
Board Of Directors
Balance Sheet
Profit & Loss
Quarterly Results
Key Financial Ratios
Share Prices
Company News
Directors Reports
Share Holding Pattern
Quoted & Unquoted Investment
Equity History
Foreign Market
Pre Session
Mid Session
End Session
FII Activities
MF Activities
 
Dr Reddys Laboratories Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
Market Cap : 70,945   Equity & F.V : 83.224322 | 5   Group : Dr. Reddy's
Latest Reserves : 18413.1   Book Value : 1111.2331033   52 Week H/L : 5078.8 | 3655
Latest Debt : 2205.4   PE & EPS : 41.51 | 102.69   Div Yield : 0.70
Date Heading
10/Aug/22 Dr Reddys Laboratories Ltd up for five straight sessions
03/Aug/22 Dr Reddys Laboratories Ltd - Announcement under Regulation 30 (LODR)-Earnings Call Tr..
03/Aug/22 Dr Reddys Laboratories Ltd - Compliances-Reg. 39 (3) - Details of Loss of Certificate..
02/Aug/22 Dr Reddys announces cessation of director
30/Jul/22 Dr Reddy's enters into licensing agreement for ophthalmic product for US market
30/Jul/22 Dr. Reddy's Labs inks agreement for private label version of Lumify with Slayback Pha..
30/Jul/22 Dr Reddy's board approves sale of its NBFC subsidiary - Imperial Credit
30/Jul/22 Dr Reddys Laboratories Ltd - Sale Of Investment In Wholly-Owned Subsidiary - Imperial..
30/Jul/22 Dr Reddys Laboratories Ltd - Newspaper Publication For Unaudited Financial Results Fo..
30/Jul/22 Dr Reddys Laboratories Ltd - Disclosure of Voting results of AGM (Regulation 44(3) of..
1 2 3  Next 
   
Back Top
Home   |   The Company   |   Portfolio Management   |   Research & Knowledge   |   Privacy & Security
© 2011, Equity Intelligence Pvt. Ltd.       Developed & powered by CMOTS Infotech (ISO 9001:2015 certified)